Early Erythrolysis in the Hematoma After Experimental Intracerebral Hemorrhage

Translational Stroke Research

Volumn 8, Issue 2, 2017, Pages 174-182

  Dang, Ge ^a,b   Yang, Yuefan ^a,c   Wu, Gang ^a   Hua, Ya ^a   Keep, Richard F ^a   Xi, Guohua ^a,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

CD163; Erythrolysis; Hematoma; Hypertension; Intracerebral hemorrhage; T2* magnetic resonance imaging

Indexed keywords

CD163 ANTIGEN; EOSIN; HEMATOXYLIN; HEMOGLOBIN; PHOSPHOPROTEIN DARPP 32; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; PPP1R1B PROTEIN, RAT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD AUTOTRANSFUSION; BRAIN; BRAIN HEMORRHAGE; CELL LOSS; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE GHOST; EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; HEMATOMA; HEMOLYSIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIHEMATOMAL NEURONAL LOSS; PRIORITY JOURNAL; RAT; STAINING; UPREGULATION; ANIMAL; ASTROCYTE; BASAL GANGLION; CELL DEATH; DIAGNOSTIC IMAGING; DISEASE MODEL; METABOLISM; MICROGLIA; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; WISTAR KYOTO RAT;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ASTROCYTES; BASAL GANGLIA; BRAIN; CELL DEATH; CEREBRAL HEMORRHAGE; DISEASE MODELS, ANIMAL; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; HEMATOMA; HEMOLYSIS; MALE; MICROGLIA; NEURONS; RATS; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; UP-REGULATION;

EID: 84992365908     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-016-0505-3     Document Type: Article

References (42)

1. Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol. 2006;5(1):53–63.
2. Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 2012;11(8):720–31.
3. Xiong XY, Wang J, Qian ZM, Yang QW. Iron and intracerebral hemorrhage: from mechanism to translation. Transl Stroke Res. 2014;5(4):429–41.
4. Selim M, Sheth KN. Perihematoma edema: a potential translational target in intracerebral hemorrhage? Transl Stroke Res. 2015;6(2):104–6.
5. Xiong XY, Yang QW. Rethinking the roles of inflammation in the intracerebral hemorrhage. Transl Stroke Res. 2015;6(5):339–41.
6. Xi G, Keep RF, Hoff JT. Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J Neurosurg. 1998;89:991–6.
7. Hua Y, Schallert T, Keep RF, Wu J, Hoff JT, Xi G. Behavioral tests after intracerebral hemorrhage in the rat. Stroke. 2002;33(10):2478–84.
8. Song S, Hua Y, Keep RF, Hoff JT, Xi G. A new hippocampal model for examining intracerebral hemorrhage-related neuronal death: effects of deferoxamine on hemoglobin-induced neuronal death. Stroke. 2007;38(10):2861–3.
9. Schellinger PD, Jansen O, Fiebach JB, Hacke W, Sartor K. A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage. Stroke. 1999;30(4):765–8.
10. Linfante I, Llinas RH, Caplan LR, Warach S. MRI features of intracerebral hemorrhage within 2 hours from symptom onset. Stroke. 1999;30(11):2263–7.
11. Etzerodt A, Moestrup SK. CD163 and inflammation: biological, diagnostic, and therapeutic aspects. Antioxid Redox Signal. 2013;18(17):2352–63.
12. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, et al. Identification of the haemoglobin scavenger receptor. Nature. 2001;409(6817):198–201.
13. Liu B, Hu B, Shao S, Wu W, Fan L, Bai G, et al. CD163/hemoglobin oxygenase-1 pathway regulates inflammation in hematoma surrounding tissues after intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2015;24(12):2800–9.
14. Cao S, Zheng M, Hua Y, Chen G, Keep RF, Xi G. Hematoma changes during clot resolution after experimental intracerebral hemorrhage. Stroke. 2016;47(6):1626–31.
15. Dandapani BK, Suzuki S, Kelley RE, Reyes-Iglesias Y, Duncan RC. Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke. 1995;26(1):21–4.
16. Wu G, Bao X, Xi G, Keep RF, Thompson BG, Hua Y. Brain injury after intracerebral hemorrhage in spontaneously hypertensive rats. J Neurosurg. 2011;114(6):1805–11.
17. Odashiro K, Saito K, Arita T, Maruyama T, Fujino T, Akashi K. Impaired deformability of circulating erythrocytes obtained from nondiabetic hypertensive patients: investigation by a nickel mesh filtration technique. Clin Hypertens. 2015;21:17.
18. Ariyoshi K, Maruyama T, Odashiro K, Akashi K, Fujino T, Uyesaka N. Impaired erythrocyte filterability of spontaneously hypertensive rats: investigation by nickel filtration technique. Circ J. 2010;74(1):129–36.
19. Wu G, Xi G, Hua Y, Sagher O. T2* magnetic resonance imaging sequences reflect brain tissue iron deposition following intracerebral hemorrhage. Transl Stroke Res. 2010;1:31–4.
20. Hatakeyama T, Okauchi M, Hua Y, Keep RF, Xi G. Deferoxamine reduces neuronal death and hematoma lysis after intracerebral hemorrhage in aged rats. Transl Stroke Res. 2013;4(5):546–53.
21. Chen Z, Gao C, Hua Y, Keep RF, Muraszko K, Xi G. Role of iron in brain injury after intraventricular hemorrhage. Stroke. 2011;42(2):465–70.
22. Zheng M, Du H, Ni W, Koch LG, Britton SL, Keep RF, et al. Iron-induced necrotic brain cell death in rats with different aerobic capacity. Transl Stroke Res. 2015;6(3):215–23.
23. Zhao J, Chen Z, Xi G, Keep RF, Hua Y. Deferoxamine attenuates acute hydrocephalus after traumatic brain injury in rats. Transl Stroke Res. 2014;5:586–94.
24. Jin H, Xi G, Keep RF, Wu J, Hua Y. DARPP-32 to quantify intracerebral hemorrhage-induced neuronal death in basal ganglia. Transl Stroke Res. 2013;4(1):130–4.
25. Wan S, Cheng Y, Jin H, Guo D, Hua Y, Keep RF, et al. Microglia activation and polarization after intracerebral hemorrhage in mice: the role of protease-activated receptor-1. Transl Stroke Res. 2016.
26. Song J, Li P, Chaudhary N, Gemmete JJ, Thompson BG, Xi G, et al. Correlating cerebral (18)FDG PET-CT patterns with histological analysis during early brain injury in a rat subarachnoid hemorrhage model. Transl Stroke Res. 2015;6(4):290–5.
27. Wang J, Jin H, Hua Y, Keep RF, Xi G. Role of protease-activated receptor-1 in brain injury after experimental global cerebral ischemia. Stroke. 2012;43(9):2476–82.
28. Wu J, Hua Y, Keep RF, Nakamura T, Hoff JT, Xi G. Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke. 2003;34(12):2964–9.
29. Koeppen AH, Dickson AC, McEvoy JA. The cellular reactions to experimental intracerebral hemorrhage. J Neurol Sci. 1995;134:102–12.
30. Marlet JM, Barreto Fonseca Jde P. Experimental determination of time of intracranial hemorrhage by spectrophotometric analysis of cerebrospinal fluid. J Forensic Sci. 1982;27(4):880–8.
31. Karuppagounder SS, Alim I, Khim SJ, Bourassa MW, Sleiman SF, John R, et al. Therapeutic targeting of oxygen-sensing prolyl hydroxylases abrogates ATF4-dependent neuronal death and improves outcomes after brain hemorrhage in several rodent models. Sci Transl Med. 2016;8(328):328ra29.
32. Martinez VG, Moestrup SK, Holmskov U, Mollenhauer J, Lozano F. The conserved scavenger receptor cysteine-rich superfamily in therapy and diagnosis. Pharmacol Rev. 2011;63(4):967–1000.
33. Graversen JH, Moestrup SK. Drug trafficking into macrophages via the endocytotic receptor CD163. Membranes (Basel). 2015;5(2):228–52.
34. Alayash AI, Andersen CB, Moestrup SK, Bulow L. Haptoglobin: the hemoglobin detoxifier in plasma. Trends Biotechnol. 2013;31(1):2–3.
35. Thomsen JH, Etzerodt A, Svendsen P, Moestrup SK. The haptoglobin-CD163-heme oxygenase-1 pathway for hemoglobin scavenging. Oxidative Med Cell Longev. 2013;2013:523652.
36. Garton TP, He Y, Garton HJ, Keep RF, Xi G, Strahle JM. Hemoglobin-induced neuronal degeneration in the hippocampus after neonatal intraventricular hemorrhage. Brain Res. 2016;1635:86–94.
37. Chen-Roetling J, Regan RF. Haptoglobin increases the vulnerability of CD163-expressing neurons to hemoglobin. J Neurochem. 2016.
38. Cicco G, Pirrelli A. Red blood cell (RBC) deformability, RBC aggregability and tissue oxygenation in hypertension. Clin Hemorheol Microcirc. 1999;21(3–4):169–77.
39. Kaczmarska M, Fornal M, Messerli FH, Korecki J, Grodzicki T, Burda K. Erythrocyte membrane properties in patients with essential hypertension. Cell Biochem Biophys. 2013;67(3):1089–102.
40. Pytel E, Duchnowicz P, Jackowska P, Wojdan K, Koter-Michalak M, Broncel M. Disorders of erythrocyte structure and function in hypertensive patients. Med Sci Monit. 2012;18(8):BR331–6.
41. Amaiden MR, Monesterolo NE, Santander VS, Campetelli AN, Arce CA, Pie J, et al. Involvement of membrane tubulin in erythrocyte deformability and blood pressure. J Hypertens. 2012;30(7):1414–22.
42. Chabanel A, Schachter D, Chien S. Increased rigidity of red blood cell membrane in young spontaneously hypertensive rats. Hypertension. 1987;10(6):603–7.